Bibliografía
Bibliografía utilizada para preparar la presente Guía
Aiello S.E., Moses M.A. (2016) The Merck Veterinary Manual, 11th Edition. Merck & Co., Inc. Kenilworth. Enlace a la publicación
Antonissen G., Martel A. (2018) Antifungal therapy in birds: old drugs in a new jacket. The Veterinary Clinics of North America. Exotic Animal Practice, 21(2):355-377. PubMed
Arendrup M.C., Meletiadis J., Mouton J.W., Lagrou K., Hamal P., Guinea J., Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2020) EUCAST DEFINITIVE DOCUMENT E.DEF 7.3.2. Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts. European Committee for Antimicrobial Susceptibility Testing. Enlace a la publicación
Azevedo M.M., Faria-Ramos I., Cruz L.C., Pina-Vaz C., Rodrigues A.G. (2015) Genesis of azole antifungal resistance from agriculture to clinical settings. Journal of Agricultural and Food Chemistry, 63(34):7463-7468. PubMed
Beardsley J., Halliday C.L., Chen S.C., Sorrell T.C. (2018) Responding to the emergence of antifungal drug resistance: perspectives from the bench and the bedside. Future Microbiology, 13(10):1175-1191. PubMed
Berkow E.L., Lockhart S.R., Ostrosky-Zeichner L. (2020) Antifungal susceptibility testing: current approaches. Clinical Microbiology Reviews, 33(3):e00069-19. PubMed
CDC (2019) Antibiotic resistance threats in the United States, 2019. Department of Health and Human Services. Centers for Disease Control and Prevention, Atlanta. Enlace a la publicación
CLSI (2017) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi, 3rd ed. CLSI standard M38. Clinical and Laboratory Standards Institute, Wayne. Enlace a la publicación
CLSI (2017) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, 4th ed. CLSI standard M27. Clinical and Laboratory Standards Institute, Wayne. Enlace a la publicación
Cowen L.E., Sanglard D., Howard S.J., Rogers P.D., Perlin D.S. (2014) Mechanisms of antifungal drug resistance. Cold Spring Harbor Perspectives in Medicine, 5(7):a019752. PubMed
Dannaoui E., Espinel-Ingroff A. (2019) Antifungal susceptibly testing by concentration gradient strip Etest method for fungal isolates: a review. Journal of Fungi, 5(4):108. PubMed
de Hoog G.S., Guarro J., Gené J., Ahmed S.A., Al-Hatmi A.M.S., Figueras M.J., Vitale R.G. (2020) Atlas of Clinical Fungi, 4th Edition. Foundation Atlas of Clinical Fungi, Hilversum. Enlace a la publicación
Fisher M.C., Alastruey-Izquierdo A., Berman J., Bicanic T., Bignell E.M., Bowyer P., Bromley M., Brüggemann R., Garber G., Cornely O.A., Gurr S.J., Harrison T.S., Kuijper E., Rhodes J., Sheppard D.C., Warris A., White P.L., Xu J., Zwaan B., Verweij P.E. (2022) Tackling the emerging threat of antifungal resistance to human health. Nature Reviews Microbiology, 20(9):557-571. PubMed
Fisher M.C., Hawkins N.J., Sanglard D., Gurr S.J. (2018) Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science, 360(6390):739-742. PubMed
Foy D.S., Trepanier L.A. (2010) Antifungal treatment of small animal veterinary patients. The Veterinary Clinics of North America. Small Animal Practice, 40(6):1171-1188. PubMed
Guinea J., Meletiadis J., Arikan‐Akdagli S., Muehlethaler K., Kahlmeter G., Arendrup M.C., Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2022) EUCAST DEFINITIVE DOCUMENT E.DEF 9.4. Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds. European Committee for Antimicrobial Susceptibility Testing. Enlace a la publicación
Johnson M.D., Perfect J.R. (2010) Use of antifungal combination therapy: agents, order, and timing. Current Fungal Infections Report, 4(2):87-95. PubMed
Klastersky J. (2004) Empirical antifungal therapy. International Journal of Antimicrobial Agents, 23(2):105-112. PubMed
Mazu T.K., Bricker B.A., Flores-Rozas H., Ablordeppey S.Y. (2016) The mechanistic targets of antifungal agents: an overview. Mini Reviews in Medicinal Chemistry, 16(7):555-578. PubMed
Moriello K.A., Coyner K., Paterson S., Mignon B. (2017) Diagnosis and treatment of dermatophytosis in dogs and cats. Clinical Consensus Guidelines of the World Association for Veterinary Dermatology. Veterinary Dermatology, 28(3):266-e68. PubMed
Perea S., Patterson T.F. (2002) Antifungal resistance in pathogenic fungi. Clinical Infectious Diseases, 35(9):1073-80. PubMed
Perlin D.S., Rautemaa-Richardson R., Alastruey-Izquierdo A. (2017) The global problem of antifungal resistance: prevalence, mechanisms, and management. The Lancet. Infectious diseases, 17(12):e383-e392. PubMed
Rochette F., Engelen M., Vanden Bossche H. (2003) Antifungal agents of use in animal health–practical applications. Journal of Veterinary Pharmacology and Therapeutics, 26(1):31-53. PubMed
Sanguinetti M., Posteraro B. (2018) Susceptibility testing of fungi to antifungal drugs. Journal of Fungi, 4(3):110. PubMed
Seyedmousavi S., Wiederhold N.P., Ebel F., Hedayati M.T., Rafati H., Verweij P.E. (2018) Antifungal use in veterinary practice and emergence of resistance. In: Seyedmousavi S., de Hoog G.S., Guillot J., Verweij P.E. (eds.) Emerging and epizonotic fungal infections in animals. Springer, Cham, Switzerland, pp 359-402. Enlace a la publicación
Wiederhold N.P. (2017) Antifungal resistance: current trends and future strategies to combat. Infection and Drug Resistance, 10:249-259. PubMed
Publicaciones de nuestro grupo de investigación relacionadas con el tema de los antifúngicos y las resistencias antifúngicas
Álvarez-Pérez S., García M.E., Anega B., Blanco J.L. (2021) Antifungal resistance in animal medicine: current state and future challenges. In: Gupta A., Pratap Singh N. (eds.) Fungal Diseases in Animals: From Infections to Prevention. Fungal Biology. Springer, Cham, pp. 163-179. Enlace a la publicación
Álvarez-Pérez S., Anega B., Díaz-de-Tuesta J.A., González-Martín J.V., Riesgo-Martínez M., García M.E., Blanco J.L. (2021) Susceptibility testing of Prototheca bovis isolates from cases of bovine mastitis using the CLSI reference broth microdilution method and the Sensititre YeastOne colorimetric panel. Medical Mycology, 59(12):1257-1261. PubMed
Álvarez-Pérez S., García M.E., Blanco J.L. (2019) In vitro activity of amphotericin B-azole combinations against Malassezia pachydermatis strains. Medical Mycology, 57(2):196-203. PubMed
Álvarez-Pérez S., García M.E., Peláez T., Martínez-Nevado E., Blanco J.L. (2016) Antifungal susceptibility testing of ascomycetous yeasts isolated from animals. Antimicrobial Agents and Chemotherapy, 60(8):5026-5028. PubMed
Álvarez-Pérez S., de Vega C., Pozo M.I., Lenaerts M., Van Assche A., Herrera C.M., Jacquemyn H., Lievens B. (2016) Nectar yeasts of the Metschnikowia clade are highly susceptible to azole antifungals widely used in medicine and agriculture. FEMS Yeast Research, 16(1):fov115. PubMed
Álvarez-Pérez S., García M.E., Cutuli M.T., Fermín M.L., Daza M.A., Peláez T., Blanco J.L. (2016) Acquired multi-azole resistance in Candida tropicalis during persistent urinary tract infection in a dog. Medical Mycology Case Reports, 11:9-12. PubMed
Álvarez-Pérez S., García M.E., Peláez T., Blanco J.L. (2016) Genotyping and antifungal susceptibility testing of multiple Malassezia pachydermatis isolates from otitis and dermatitis cases in pets: is it really worth the effort? Medical Mycology, 54(1):72-79. PubMed
Álvarez-Pérez S., Blanco J.L., Peláez T., Cutuli M., García M.E. (2014) In vitro amphotericin B susceptibility of Malassezia pachydermatis determined by the CLSI broth microdilution method and Etest using lipid-enriched media. Antimicrobial Agents and Chemotherapy, 58(7):4203-4206. PubMed
En negrita se muestran los nombres de los autores de la presente Guía.